List of Excipients in API lamotrigine er
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing lamotrigine er
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 | FD&C BLUE NO. 2 |
| Direct_Rx | lamotrigine er | 72189-467 | FERROSOFERRIC OXIDE |
| Direct_Rx | lamotrigine er | 72189-467 | GLYCERYL MONOSTEARATE |
| Direct_Rx | lamotrigine er | 72189-467 | HYPROMELLOSES |
| Direct_Rx | lamotrigine er | 72189-467 | LACTOSE MONOHYDRATE |
| Direct_Rx | lamotrigine er | 72189-467 | MAGNESIUM STEARATE |
| Direct_Rx | lamotrigine er | 72189-467 | METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for lamotrigine er
Excipient focus: FD&C BLUE NO. 2
lamotrigine er drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
lamotrigine er drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO AND DIPALMITOSTEARATE
lamotrigine er drug variants containing GLYCERYL MONO AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing GLYCERYL MONO AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
lamotrigine er drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
lamotrigine er drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
lamotrigine er drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
lamotrigine er drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lamotrigine er drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
lamotrigine er drug variants containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
lamotrigine er drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
lamotrigine er drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
lamotrigine er drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
lamotrigine er drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
lamotrigine er drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
lamotrigine er drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lamotrigine er drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
lamotrigine er drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
lamotrigine er drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Direct_Rx | lamotrigine er | 72189-467 |
| >Company | >Ingredient | >NDC |
lamotrigine er drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Direct_rx | lamotrigine er | 72189-560 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links